PubMed COVID-19 Clinical Care

Indoor contaminant removal over 0.5 ≤ FrT ≤ 5.0, 0.5 ≤ N ≤ 5.0, and 50 ≤ Re ≤ 500 was investigated numerically, wherein Fr(T) refers to the Froude number, N refers to the buoyancy ratio, and Re refers to the Reynolds number. As demonstrated, the

Since Doxil's first clinical approval in 1995, lipid nanoparticles have garnered great interest and shown exceptional therapeutic efficacy. It is clear from the licensure of two RNA treatments and the mRNA-COVID-19 vaccination that lipid

The reaction of the scientific community against the COVID-19 pandemic has generated a huge (approx. 10⁶ entries) dataset of genome sequences collected worldwide and spanning a relatively short time window. These unprecedented conditions together

CONCLUSION: Individual factors were pivotal in Japan, whereas interpersonal factors were more likely related to perceived control in the United States. Additionally, in both countries, policy or organizational factors significantly influenced

Increased dupilumab utilization coincided with decreased ESS in patients with CRSwNP between 2019 and 2021. One potential confounder was the concurrent COVID-19 pandemic, which may have negatively impacted surgery utilization rates.

CONCLUSION: Influenza VUR increased during the Covid-19 pandemic, but only a minority of previously eligible but unvaccinated at-risk patients were vaccinated for the first time in the first pandemic season. Previous vaccinations are predictors for

SARS-CoV-2 is continuously evolving. The Omicron subvariant BA.2.86, with >30 mutations in its spike (S) protein compared with its predecessor strain BA.2, was expected to quickly become predominant worldwide, but this has not happened. Instead, its

We would like to share our ideas on the recently published article, "Psoriatic arthritis and COVID-19: Patient perspectives in a large psoriatic arthritis cohort."¹ The purpose of this study was to determine the prevalence of the coronavirus disease

In the last few years, mRNA therapeutics experienced a new wave of interest as therapy for retinal diseases. Nevertheless, despite the widespread use of mRNA vaccines in the COVID-19 pandemic, mRNA delivery to the eye is still in its infancy

CONCLUSIONS: There are still many missed opportunities in the prevention and diagnosis of childhood TB. The positive legacy of the COVID-19 pandemic should be taken advantage of and the encouragement of scientific development in the management of